... of 39.8 months, no biochemical relapse was observed. Conclusion: To date, there is no clear evidence to withhold TRT from hypogonadal men after curative PCa treatment. Our findings, although with limitations, fit in with the available data showing that TRT does not put patients at an increased risk after...

... filled with 21–23 mg testosterone and implanted in castrates, hypogonadal and subfertile men had a releasing factor of approximately 55 µg/24 h/capsule and a therapeutic effect of about 13 months. The clinical results of testosterone substitution in castrates and hypogonadal men were good as judged...